Prospective comparison of liquid biopsy to standard of care tissue testing in metastatic, non-squamous, non-small cell lung cancer (NSCLC) patients (pts)

被引：0
|
作者：
Palmero, R. [1 ]
Taus, A. [2 ]
Majem Tarruella, M. [3 ]
Viteri, S. [4 ]
Costa, E. Carcereny [5 ]
Garde, J. [6 ,7 ]
Felip Font, E. [8 ]
Cassidy, C. [9 ]
Dix, D. [9 ]
Karachaliou, N. [4 ]
Rosell, R. [4 ,5 ]
机构：
[1] Catalan Inst Oncol, Lhospitalet De Llobregat, Spain
[2] Del Mar Hosp, Barcelona, Spain
[3] Santa Creu & St Pau Hosp, Barcelona, Spain
[4] Dexeus Univ Hosp, QuironSalud Grp, Inst Oncol Dr Rosell, Barcelona, Spain
[5] Germans Trias & Pujol Hlth Sci Inst & Hosp, Catalan Inst Oncol, Badalona, Spain
[6] Arnau de Vilanova Univ Hosp, Valencia, Spain
[7] Medica Scientia Innovat Res MEDSIR ARO, Barcelona, Spain
[8] Vall dHebron Univ Hosp, Barcelona, Spain
[9] Guardant Hlth Inc, Redwood City, CA USA
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1384TiP
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Maintenance chemotherapy in patients with non-squamous non-small cell lung cancer (NSCLC)
    Belalcazar, A.
    Santos, E. S.
    Gomez, J. E.
    Lopez, E.
    Raez, L. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Treatment algorithms for patients with metastatic non-small cell, non-squamous lung cancer
    Melosky, Barbara
    [J]. FRONTIERS IN ONCOLOGY, 2014, 4
  • [3] Molecular testing in older patients treated for an advanced or metastatic non-squamous non-small cell lung cancer
    Lamy, T.
    Cabarrou, B.
    Planchard, D.
    Quantin, X.
    Schneider, S.
    Bringuier, M.
    Besse, B.
    Perol, M.
    Girard, N.
    Schott, R.
    Chouaid, C.
    Ricordel, C.
    Gervais, R.
    Debieuvre, D.
    Audigier-Valette, C.
    Carton, M.
    Filleron, T.
    Simon, G.
    Robain, M.
    Baldini, C.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1243 - S1244
  • [4] Impact of reflex testing for EGFR mutations in non-squamous non-small cell lung cancer (NSCLC).
    Cheema, Parneet Kaur
    Victor, Charles
    Dolley, Aastha
    Dziarmaga, Alison
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Current Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer
    Melosky, Barbara
    [J]. FRONTIERS IN ONCOLOGY, 2017, 7
  • [6] KRAS molecular profiling in non-squamous non-small cell lung cancer (NSCLC).
    Karim, Nagla Abdel
    Starnes, Sandra
    Morris, John
    Pathrose, Peter
    Perry, Ashley
    Fathallah, Hassana
    [J]. CLINICAL CANCER RESEARCH, 2014, 20
  • [7] Impact of Reflex Testing on Pathology Based Molecular Testing in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
    Marmarelis, M.
    Berman, A.
    Scholes, D.
    Thompson, J.
    Doucette, A.
    Gabriel, P.
    Bauml, J.
    Singh, A.
    Cohen, R.
    Litzky, L.
    Mcgrath, C.
    Feldman, M.
    Langer, C.
    Carpenter, E.
    Aggarwal, C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1157 - S1157
  • [8] EFFECTIVENESS AND TOLERANCE OF MAINTENANCE THERAPY IN PATIENTS WITH NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
    Santos, E. S.
    Belalcazar, A.
    Vazquez, A.
    Gomez, J. E.
    Raez, L. E.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S97 - S97
  • [9] MOLECULAR TESTING IN NON-SQUAMOUS NON-SMALL CELL LUNG CANCER AND THE ROLE OF LIQUID CYTOLOGY SPECIMENS
    Moore, S.
    Loff, K.
    Murphy, M.
    [J]. RESPIROLOGY, 2020, 25 : 60 - 60
  • [10] Atezolizumab in non-squamous non-small cell lung cancer
    Akamine, Takaki
    Toyokawa, Gouji
    Tagawa, Tetsuzo
    Seto, Takashi
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S3155 - S3159
12345